All tools and calculators

Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
FreseniusEli Lilly
Last price
€45.28$1,270.75
Currency
EUR
USD
€25B$1.1T
16.4443.09
€2.71$29.79
0.830.45
€1.05$6.69
2.36%0.54%
Sector
HealthHealth
Employees
178,48650,000
Ticker
€FRE$LLY
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €FRE or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.
Sign up